Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have received an $800,000 grant from the V Foundation to find new ways to treat and prevent a severe...
There’s a frustrating fact about today’s immunotherapies for cancer. While sometimes they work beautifully -; completely eliminating or greatly reducing cancer in particular patients -; other times...
Scientists at Washington State University, USA, have conducted a clinical trial to investigate the acute effect of cannabigerol on anxiety, stress, and mood in healthy individuals....
In a recent review published in the journal Frontiers Endocrinology, researchers collate and elucidate recent clinical and pathophysiological knowledge on Tirzepatide. This novel anti-obesity and weight...
A potential new treatment for bipolar disorder (BP) that significantly shortens treatment time has emerged, following a randomized clinical trial using accelerated intermittent theta burst stimulation...
Mayo Clinic announces a groundbreaking achievement in organ transplantation, offering hope to thousands who have lost their ability to speak, swallow and breathe on their own due...
In a recent study published in JAMA Internal Medicine, researchers examine the potential of neuromuscular training to prevent chemotherapy-induced peripheral neuropathy (CIPN). Study: Preventive Effect of Neuromuscular...
Oran, who had been having severe epileptic seizures for eight years and often needed resuscitation, was the first child in the UK to have this device...
The first participants have been dosed in SAFYR, a Phase I clinical trial to test the safety and efficacy of two prophylactic vaccines developed with AstriVax...
Adding an anti-inflammatory drug to anti-PD1 checkpoint inhibitor immunotherapy has shown great promise as a new strategy against advanced lung cancer, based on results from a...
Researchers at Washington University School of Medicine in St. Louis have found that safety interventions – such as walkers, grab bars, ramps and other home modifications...
An analysis of data from a randomized clinical trial for patients with stage 3 colon cancer found that those with PIK3CA mutations who took celecoxib, an...